We specifically focused on mutation analysis of RAB27A, LYST, and AP3B1 in patients with FHL with pigment dilution, as well as a cohort with no clinical evidence of pigment dilution but no mutations in the other known FHL-related genes. This evidence concerns the gene AP3B1 and hemophagocytic syndrome.